HTG Molecular Diagnostics, Inc.

Simbol: HTGM

NASDAQ

0.48

USD

Tržna cena danes

  • -0.0745

    Razmerje P/E

  • -0.0008

    Razmerje PEG

  • 1.06M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

HTG Molecular Diagnostics, Inc. (HTGM) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za HTG Molecular Diagnostics, Inc. (HTGM). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja HTG Molecular Diagnostics, Inc., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

39.412.221.928.7
33
31.1
10
11.8
31.5
3.6
1.8
7.3

balance-sheet.row.short-term-investments

15.23012.36.3
25.4
22.7
0
4.3
28.2
0
0
0

balance-sheet.row.net-receivables

4.771.42.11.6
3.2
5
6.4
1.4
0.7
0.8
0.6
0.2

balance-sheet.row.inventory

5.210.921.5
1.3
1.3
1.2
1.5
2.2
1.5
0.7
0.1

balance-sheet.row.other-current-assets

4.891.11.21.1
0.6
0.6
0.4
0.4
0.4
0.1
0.2
0.2

balance-sheet.row.total-current-assets

54.9415.727.232.9
41.4
38
17.9
15.1
34.9
6
3.3
7.8

balance-sheet.row.property-plant-equipment-net

6.651.62.52.2
3.4
2.4
3.3
3.3
1.9
1.4
1.1
0.6

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
2.6
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2.880.50.80.1
0.3
3.4
0
0
0.1
1.4
0
0

balance-sheet.row.total-non-current-assets

9.522.13.32.3
3.8
5.8
3.3
3.3
4.6
2.7
1.1
0.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

64.4617.830.535.2
45.1
43.8
21.3
18.5
39.4
8.7
4.4
8.4

balance-sheet.row.account-payables

4.081.21.61.3
1.7
1.8
2.4
0.8
0.7
0.9
0.8
0.6

balance-sheet.row.short-term-debt

19.024.35.63.7
3.7
0
5.8
6.4
3.1
0.8
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

4.920.56.18.9
7.5
9.7
3
5.4
7.8
10.4
0
0.2

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

8.712.82.62
3.1
4.8
4.4
2.5
2.5
1.5
1.5
1.1

balance-sheet.row.total-non-current-liabilities

20.014.110.113.5
12.3
15.7
11
14
16.2
29.5
24.5
24.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

3.4111.41.1
1.4
0
0
0
0
0
0
0

balance-sheet.row.total-liab

51.8112.420.120.7
21.1
22.7
24.3
24
22.6
32.8
26.8
26.7

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
45.6
35.8
25.9

balance-sheet.row.common-stock

0.03000
0.1
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-910.86-229.9-208.3-191.2
-170.3
-151
-134.6
-115.6
-89.6
-68.2
-54.2
-42.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.02000
0
0
0
0
0
-2
-1.5
-1.2

balance-sheet.row.other-total-stockholders-equity

923.5235.3218.7205.7
194.2
172.1
131.5
110
106.5
0.5
-2.6
-0.6

balance-sheet.row.total-stockholders-equity

12.645.410.414.5
24
21.1
-3.1
-5.6
16.9
-24
-22.4
-18.3

balance-sheet.row.total-liabilities-and-stockholders-equity

64.4617.830.535.2
45.1
43.8
21.3
18.5
39.4
8.7
4.4
8.4

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

12.645.410.414.5
24
21.1
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

64.46---
-
-
-
-
-
-
-
-

Total Investments

15.23012.36.3
25.4
22.7
0
4.3
30.8
0
0
0

balance-sheet.row.total-debt

23.944.811.712.6
11.3
32.4
8.8
11.8
10.8
11.2
0
0.2

balance-sheet.row.net-debt

-0.24-7.42.1-9.8
3.6
23.9
-1.2
4.3
7.6
7.6
-1.8
-7.1

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju HTG Molecular Diagnostics, Inc. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

cash-flows.row.net-income

-20.15-21.6-17.1-20.9
-19.3
-16.5
-19
-26
-21.4
-14
-11.8
-12.8

cash-flows.row.depreciation-and-amortization

0.490.60.71.3
1.7
1.5
1.2
1.5
0.7
0.5
0.3
0.2

cash-flows.row.deferred-income-tax

00-1.40.7
0.2
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0.680.81.41.8
1.2
1.9
1.4
1
0.4
0.2
0.1
0.1

cash-flows.row.change-in-working-capital

-0.16-0.1-1-0.2
-0.5
0
-1.2
-0.3
-0.9
-0.7
-0.5
1.3

cash-flows.row.account-receivables

-0.380.7-0.81.6
1.8
1.3
-5
-0.7
0
-0.3
-0.5
1.7

cash-flows.row.inventory

0.270.1-1.4-0.3
-0.1
-0.2
0.1
0
-0.7
-0.7
-0.6
-0.1

cash-flows.row.account-payables

-0.2-0.50.50
-0.2
-0.2
1.2
0
-0.3
0.2
0.1
0

cash-flows.row.other-working-capital

0.16-0.40.7-1.5
-2.1
-1
2.5
0.4
0.1
0.2
0.4
-0.3

cash-flows.row.other-non-cash-items

2.311.90.90.9
0
-0.2
0.9
1.6
2
0.9
0.1
2.5

cash-flows.row.net-cash-provided-by-operating-activities

-16.83000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.020-0.6-0.5
-1.1
-0.9
-1
-1.9
-1.3
-0.9
-0.8
-0.1

cash-flows.row.acquisitions-net

-99828.510-25018-72.5
-325666
-412436
0
172
0
0
0
0

cash-flows.row.purchases-of-investments

-11.15-7.6-18.6-12.5
-34.6
-54
0
-3.4
-38.3
0
0
0

cash-flows.row.sales-maturities-of-investments

14.5219.912.631.6
32.2
31.7
4.3
29.8
7.5
0
0
0

cash-flows.row.other-investing-activites

99828.640.12501872.5
325666
412436
0
-172
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

3.4812.4-6.718.7
-3.5
-23.2
3.3
24.4
-32.2
-0.9
-0.8
-0.1

cash-flows.row.debt-repayment

-7.16-7.8-0.8-3.6
0
-6
-6.5
-4.6
0
-0.8
0
0

cash-flows.row.common-stock-issued

2.81.410.77.5
20.8
38.3
20.2
2
47.7
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
-1165.9
0
0
0

cash-flows.row.other-financing-activites

6.09150.55.1
-1.3
5.9
2
4.6
1169.4
16.4
7.1
7.2

cash-flows.row.net-cash-used-provided-by-financing-activities

1.738.610.49
19.4
38.1
15.8
2
51.1
15.7
7.1
7.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-11.622.6-12.811.5
-0.8
1.7
2.5
4.2
-0.3
1.8
-5.5
-1.6

cash-flows.row.cash-at-end-of-period

24.1812.29.622.4
10.9
11.7
10
7.5
3.3
3.6
1.8
7.3

cash-flows.row.cash-at-beginning-of-period

35.799.622.410.9
11.7
10
7.5
3.3
3.6
1.8
7.3
8.9

cash-flows.row.operating-cash-flow

-16.83-18.4-16.5-16.3
-16.7
-13.2
-16.6
-22.2
-19.2
-13
-11.8
-8.7

cash-flows.row.capital-expenditure

-0.020-0.6-0.5
-1.1
-0.9
-1
-1.9
-1.3
-0.9
-0.8
-0.1

cash-flows.row.free-cash-flow

-16.85-18.4-17.2-16.7
-17.8
-14.1
-17.6
-24.2
-20.6
-13.9
-12.6
-8.7

Vrstica izkaza poslovnega izida

Prihodki HTG Molecular Diagnostics, Inc. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja HTGM znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

6.216.48.98.5
19.2
21.5
14.8
5.1
4
3.3
2.2
2.5

income-statement-row.row.cost-of-revenue

4.874.64.14
8.9
5.1
5
4.1
3.3
3.2
2.2
1.8

income-statement-row.row.gross-profit

1.351.84.84.6
10.3
16.4
9.8
1
0.7
0.1
0
0.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

6.47---
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-0.240-10
0
0
0
0
0
9.9
7.7
7.3

income-statement-row.row.operating-expenses

20.9422.622.624.1
29.3
32.6
27.5
25.3
19.6
13
11.9
11.2

income-statement-row.row.cost-and-expenses

25.827.226.728.1
38.2
37.7
32.5
29.5
22.9
16.2
14.2
13

income-statement-row.row.interest-income

0.190.100.3
0.6
0.7
0.1
0.1
0.1
0
0
0

income-statement-row.row.interest-expense

0.750.91.11
1
0.9
1.3
1.9
1.7
0.7
0.2
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.55-0.80.7-1.3
-0.3
-0.3
-1.2
-1.7
-2.5
-1.1
0.1
-2.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-0.240-10
0
0
0
0
0
9.9
7.7
7.3

income-statement-row.row.total-operating-expenses

-0.55-0.80.7-1.3
-0.3
-0.3
-1.2
-1.7
-2.5
-1.1
0.1
-2.2

income-statement-row.row.interest-expense

0.750.91.11
1
0.9
1.3
1.9
1.7
0.7
0.2
0.3

income-statement-row.row.depreciation-and-amortization

0.550.7-1.71.6
2.4
1.5
1.2
1.5
0.7
0.5
0.3
0.2

income-statement-row.row.ebitda-caps

-19.29---
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-19.59-20.8-17.8-19.6
-19
-16.2
-17.7
-24.3
-18.9
-12.8
-11.9
-10.5

income-statement-row.row.income-before-tax

-20.14-21.6-17.1-20.9
-19.3
-16.5
-19
-26
-21.4
-14
-11.8
-12.8

income-statement-row.row.income-tax-expense

0.01000
0
0
0
0
0
-0.4
0.4
-2

income-statement-row.row.net-income

-20.15-21.6-17.1-20.9
-19.3
-16.5
-19
-26
-21.4
-14
-11.8
-12.8

Pogosto zastavljeno vprašanje

Kaj je HTG Molecular Diagnostics, Inc. (HTGM) skupna sredstva?

HTG Molecular Diagnostics, Inc. (HTGM) skupna sredstva so 17777655.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 3471815.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.184.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -4.967.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -3.020.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -2.946.

Kaj je HTG Molecular Diagnostics, Inc. (HTGM) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -21594476.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 4833948.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 22623682.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 2996409.000.